Research Leadership

Principal Investigator: Good Participatory Practice Mapping Project. Study is a component of the Coalition to Accelerate and Support Prevention Research (CASPR), an AVAC-led and USAID-funded project (Cooperative Agreement AID-OAA-A-16-00031). We are using global surveys to develop a framework for evaluating Good Participatory Practice in clinical trials for HIV, TB, and other emerging (and re-emerging) pathogens. 2016-2021

Principal Investigator: Building Healthy Communities: Learning from the Partnership for a Healthy Durham. Participatory evaluation study of the experience of the Partnership for a Healthy Durham, a coalition of local organizations and community members who work together to improve the physical, mental, and social health and well-being of residents in Durham, North Carolina. FHI Foundation funding. 2015-2016

Principal Investigator/Project Director: Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Rings. The objective of this project was to create a coherent, validated, and feasible adherence measurement and support package for use in ARV-based vaginal ring trials. The package integrated evidence and best practices related to adherence measurement and support together with promising biomedical innovations. USAID funding, Cooperative Agreement AID-OAA-A-14-00003. 2013-2016

Principal Investigator: Developing a Theory of Change for Evaluating Participatory Practices in TB Trials. Funded by NIAID/NIH, R21AI108519. 2013-2015

Co-Principal Investigator (with E. Costenbader): Piloting an Organizational Network-Building tool to Assess HIV Service Linkages in Durham, North Carolina. Funded by UNC CFAR Developmental Award. 2013-2014

Project Director and Co-Principal Investigator (with K. Torjesen): CAPRISA 106 Tenofovir Gel Social and Health Systems Research Study. USAID funding. 2012-2014

Scientific Lead: Gender and Multiple and Concurrent Sexual Partnerships in Zambia. Jointly funded by the National AIDS Commission Zambia, United Nations, and USAID. 2009-2011

Principal Investigator: 2008-2013: A Partnership Initiative for HIV Prevention Trials (LinCS 2 Durham). NINR/NIH 1R01NR011232. 2008-2013

Scientific Lead: Gender and Multiple and Concurrent Sexual Partnerships in Lesotho. Jointly funded by UNAIDS and USAID; collaboratively led with National AIDS Commission Lesotho and UNAIDS. 2007-2008

Principal Investigator: CAPRISA 104: Microbicide Case Control Study to Evaluate Behavioural Patterns of Risk and Gel Use in a Phase 2b Trial. USAID funding. 2007-2013

Principal Investigator: HIV Prevention Trials Network Partnering for Care Project. NIAID/NIH HIV Prevention Trials Network funding. 2004-2006

Principal Investigator: Formative Research for a Phase 2b Preventive HIV Intervention Trial With Tenofovir in Africa. Bill and Melinda Gates Foundation funding. 2002-2007

Principal Investigator: Evaluation of Standard of Care in Research Settings: A Preparedness Study for HPTN Protocol 035. NIAID/NIH HIV Prevention Trials Network funding. 2002-2004

Principal Investigator: Assessment of Willingness to Participate in a Prospective HIV Vaccine Efficacy Trial among Injecting Drug Users in Bangkok, Thailand. CDC funding. 1996-1998

CDC Project Director: Project LinCS: Linking Communities and Scientists. Jointly funded by NIAID/NIH and CDC. 1995-1998

CDC Project Director: CDC Collaborative HIV Seroincidence Study. Jointly funded by NIAID/NIH and CDC. 1992-1994